MARS Bioimaging
Brief
MARS Bioimaging is a Christchurch, New Zealand–based medical imaging company developing portable imaging technology that delivers premium imaging in community-based settings.
Profile
MARS imaging systems leverage advanced Medipix detector technology developed at the European Laboratory for Particle Physics (CERN) by the Medipix3 Collaboration, which includes the University of Canterbury.
MARS Bioimaging holds the exclusive licence from CERN to deploy this technology for medical imaging in point-of-care settings.
Headquarters
